Background In survival analyses of longitudinal data, death is often a competing event for the disease of interest, and the time-to-disease onset is interval-censored when the diagnosis is made at intermittent follow-up visits. As a result, the disease status at death is unknown for subjects disease-free at the last visit before death. Standard survival analysis consists in right-censoring the time-to-disease onset at that visit, which may induce an underestimation of the disease incidence. By contrast, an illness-death model for intervalcensored data accounts for the probability of developing the disease between that visit and death, and provides a better incidence estimate. However, the two approaches have never been compared for estimating the effect of exposure on disease risk.
Introduction
The objective of a longitudinal study is often to investigate the association between some exposures and the risk of developing a chronic disease. Standard survival analysis is usually conducted, which requires the time-to-onset of disease to be known exactly for subjects who develop the disease. However, the diagnosis may be made at intermittent follow-up visits only. The time-to-onset of disease is therefore interval-censored between the diagnostic visit and the previous one.
Standard estimation of the Cox model does not handle interval censoring. The time-to-onset of disease is thus commonly imputed by either (i) the time at diagnostic visit, 1 or (ii) the time at the midpoint of the interval between that visit and the previous one. [2] [3] [4] However, this can lead to biased effect estimates 2, 5 and may underestimate standard errors, 6 especially if the intervals are wide and of various lengths. Specific techniques for interval-censored data should therefore be preferred. 7, 8 Interval censoring further complicates competing risk analyses. Yet, death is often an important competing event that should be accurately accounted for, especially in elderly cohorts. To account for death as a competing event, a cause-specific proportional hazards model can be used. [9] [10] [11] [12] This simply refers to using a Cox model censoring for death. More specifically, the time-to-disease onset of subjects who die before being diagnosed with the disease should be right-censored at the time-to-death which is usually known exactly in cohort studies. However, because the disease status is known at intermittent visits only, there is an uncertainty on whether the subjects developed the disease between the last (disease-free) visit and death. Standard cause-specific analysis thus consists in censoring the time-to-onset of disease at the last visit rather than at death. However, subjects who are censored at time t because of death at time t'4t may be at higher risk of disease between t and t', which induces an underestimation of the disease incidence. 13 By contrast, an illness-death model for interval-censored data allows subjects to develop the disease between last visit and death or latest news on vital status. [13] [14] [15] [16] In addition, the illness-death model allows simultaneous estimation of the exposure effects not only on disease and on death in diseasefree subjects, but also on death in diseased subjects. Although the advantages of the illness-death model for interval-censored data have been demonstrated for estimating disease incidence, 13, 15 its superiority over the standard (cause-specific) Cox model remains unclear for estimating the effect of exposures on the risk of disease.
The objective of the present study is to compare the results from these different approaches for estimating the effects of exposures on the risk of disease, when death is a competing event and the disease status at death may be unknown. In the next section, we describe the regression models corresponding to each approach. A simulation study section then compares the performance of the regression models, in particular to investigate how the association between the exposure and death may affect estimates of the exposure effect on disease. Finally, an application to dementia is presented. We compare the results of the regression models for estimating the effects of selected risk factors on dementia, using data from the French elderly population-based PAQUID cohort. 3 
Regression models
The regression models differed mostly in the way they handled interval censoring and competition with death. To illustrate their difference, we selected four subjects (Table 1) of the PAQUID study where 3777 participants aged 65 years or more were recruited in 1988-90 and then screened for dementia every 2 or 3 years. 3 Because age was a strong potential confounder and entry into the cohort did not correspond to any relevant event in the subject's life course, all regression models in the simulations and application used age as the time-scale and left-truncation to account for delayed entry into the cohort. Never diagnosed with dementia and alive at the latest follow-up (n ¼ 545, i.e. 15% of subjects in the PAQUID study) The standard Cox models (Models 1 and 2) Models 1 and 2 were standard (cause-specific) Cox models written:
where t Z j ð Þ was the hazard of getting the disease at age t for a subject with covariate vector Z, 0 t ð Þ was the unspecified baseline hazard and b was the vector of regression coefficients that measured the effect of Z on the hazard of getting the disease. For Subjects C and D (Table 1 ) who were diagnosed with the disease, the age at disease onset was imputed at the age at the diagnostic visit for Model 1, and at the age at midpoint of the interval between that visit and the previous one for Model 2 ( Figure 1A ). For Subjects A and B (Table 1 ) who were never diagnosed with the disease, the age at disease onset was right-censored at the last visit in both Models 1 and À2 ( Figure 1B) , therefore not accounting for the probability of having developed the disease between that visit and death for Subject B or latest news on vital status for Subject A. The regression coefficients b in both models were estimated using standard partial likelihood available in most statistical software.
The Weibull model accounting for interval censoring (Model 3) To investigate the advantage of accounting for interval censoring but not for the probability of developing the disease between the last visit and death or latest news on vital status, we used a parametric survival model where the age at disease onset Models imputing the age at disease onset vs models accounting for interval censoring: example of Subject D (data in Figure 1 Different modelling strategies when investigating the impact of risk factors on the risk of developing the disease of interest: illustration using data from two selected subjects of the PAQUID study, France, 1988 France, -2010 was interval-censored for Subjects C and D, but still right-censored at the last disease-free visit for Subjects A and B (Figure 1 ). Model 3 assumed a Weibull distribution for 0 t ð Þ in Equation (1), which allowed estimation of b via the full likelihood (see expression in Joly et al.
18
) implemented in the SmoothHazard R package.
The semi-parametric illness-death model accounting for interval censoring (Model 4) To account for both interval censoring and the probability of developing the disease between the last disease-free visit and death or latest news, we used an illness-death model for interval-censored data. 13 Model 4 relied on three states: disease-free (State 0), diseased (State 1) and dead (State 2), as illustrated in Figure 2 . The transition intensities between the states were written:
where kl t Z j ð Þ was the intensity of transition from state k to l (k!l) at age t for a subject with covariate vector Z, kl,0 t ð Þ was the unspecified baseline intensity of transition k!l and b kl was the vector of regression coefficients that measured the effect of Z on the intensity of transition k!l. The exponential of each regression coefficient can be interpreted as a hazard ratio (HR) as in Models 1-3. The covariates Z were the same for all transitions, although this is not necessarily requested. All regression coefficients were simultaneously estimated using a penalized likelihood (see expression in Joly et al.
13
) implemented in the SmoothHazard R package, which also provides smooth estimates of kl,0 t ð Þ without parametric assumptions. Note that this procedure requires information on death even after disease diagnosis.
The proportional transition intensities assumption in Equation (2) can be explored for each covariate on each transition k!l by checking the proportionality of the curves of the penalized likelihood estimates of kl , for each group defined by the covariate. The fit of candidate models can be compared using an approximation of the likelihood cross-validation 19 that reduces to the Akaike Information Criterion (AIC) when the likelihood is not penalized.
Model 4 is a Markov model because each transition intensity depends on age only and not on the time spent in the current state. 15 It thus assumes that the mortality rate in diseased subjects does not depend on disease duration. Model 4 is non-homogeneous because transition intensities can vary with age t, and is thus more flexible than homogeneous models that assume constant intensities. 20, 21 Because Model 4 was estimated using penalized likelihood that avoids making parametric assumption on baseline transition intensities and provides smooth estimates of them, it is more flexible than fully parametric models or models assuming piecewise constant intensities with only few intervals. 22, 23 Model 4 is time-continuous as opposed to discrete-time models which are usually used when participants are observed at the same equally spaced time points. 21, 24 Simulation study Simulation design A total of 500 datasets of 2000 subjects each were generated for each scenario. Age at entry into the cohort was generated from a uniform distribution on [0,5] to which we added 65 to mimic delayed entry after the age of 65 years in the PAQUID study. Ages at disease onset and death were generated from equation (2) using Weibull distributions such that 12,0 ðtÞ 4 02,0 ðtÞ 4 01,0 ðtÞ. Transition intensities depended on one binary time-independent exposure Z. Exposure prevalence varied from 5% to 50%, but results are shown for 40% only because there were similar for other percentages. The exposure had an effect on disease only (Scenario 1), death only (Scenario 2) or both, with or without differential effect on death in diseased and disease-free subjects (Scenarios 3-6). The regression coefficients b 01 , b 02 and b 12 corresponding to each scenario are shown in Table 2 . Administrative right-censoring was independently generated from a uniform distribution. Prescheduled visit times were independently generated from uniform distribution with consecutive visits spaced in average of 2.5 years. For each scenario, low to high event rates were generated. The resulting average percentages of subjects who died, developed the disease, and were undiagnosed because of death are shown in Table 2 . Figure 2 Graphical representation of the illness-death regression model (Model 4), where 01 t Z j ð Þ, 02 t Z j ð Þ, and 12 t Z j ð Þ are transition intensities. The transition from state 0 to state 1 is unidirectional for irreversible diseases, as most chronic diseases. If age is used as the time-scale, 01 t Z j ð Þ can be interpreted as the incidence of the disease at age t for subjects with covariate values Z, 02 t Z j ð Þ as the mortality rate at age t for disease-free subjects with covariate values Z, and 12 t Z j ð Þ as the mortality rate at age t for diseased subjects with covariate values Z. The set of covariates Z may differ from one transition to another Each of the 500 data sets was analysed with Models 1-4. For each model, we calculated the relative bias of the estimates of the exposure effect on the risk of disease 01 À 01 . 01 , where 01 was the mean of the 500 effect estimates and b 01 the true effect of the exposure (log HR). A positive relative bias indicates an overestimation of the exposure effect, a negative indicates an underestimation. To measure the accuracy of the estimates, we computed the root mean square error (RMSE) that accounts not only for the bias but also for the variance of the 500 estimates ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi 01 À 01 2 þ var 01 r . The lower the RSME, the more accurate the effect estimates. To assess the accuracy of the variance estimator s and its impact on the 95% confidence interval (CI), 01 AE 1:96 Â s 01 , we calculated the proportion of the 500 data sets for which the 95% CI included the true value b 01 . The closer to 0.95 the coverage probability, the more accurate the effect and variance Undiagnosed disease because of death 4 4 8 a For each of the 500 data sets, we calculated the percentage of subjects who died among the 2000 subjects, the percentage of subjects who developed the disease before dying or being administratively censored among the 2000 subjects, and the percentage of subjects who died before being diagnosed with the disease (i.e. between the onset of disease and the diagnostic visit) among subjects who developed the disease. The percentages indicated are the average percentages on the 500 data sets.
estimates. Note that for Scenario 2 where the exposure had no effect on disease (b 01 ¼ 0), the relative bias could not be derived because the denominator equalled zero, and one minus the coverage probability gave the observed type I error of the Wald test. An observed type I error higher than 5% indicates that the test tends to wrongly reject the null hypothesis too often.
Simulation results
When the exposure was not associated with death (Scenario 1), all models gave almost unbiased effect estimates on the risk of disease (Table 3) . When the exposure increased the risks of death but had no impact on disease (Scenario 2), the type-I errors varied between 4.4% and 8.2% and suggested a slight tendency for Models 1-3 to reject the null hypothesis too often when the mortality rates were high. When the exposure affected both disease and death (Scenarios 3-6), the relative bias from Models 1-3 tended to increase with mortality rates, reaching values as high as À88.4% in Scenario 4. The estimates from Model 3 accounting for interval censoring were very close to the biased estimates from Model 2 using midpoint imputation. Thus, accounting for interval censoring was not sufficient. The much better performance of Model 4 in terms of both relative bias (all lower than 13%) and RMSE (all lower than those from Models 1-3 in Scenarios 3-6) is therefore due to its ability to account for the probability of developing the disease between the last visit and death. The coverage rate close to 95% for Model 4 further suggests that the variance estimator based on the In Scenario 2 where the exposure had no effect on disease (b 01 ¼ 0), the relative bias could not be derived because the denominator equalled zero. In addition, one minus the coverage probability gives the observed type I error for the Wald test.
penalized likelihood provides accurate estimates of the true variance. The direction and magnitude of the bias from Models 1-3 depended on the scenario (Table 3) . When the effect of the exposure on death was much stronger in disease-free than in diseased subjects and much stronger than on disease (Scenario 3), exposed subjects tended to die before developing the disease. In Models 1-3, the age at disease onset for these subjects was right-censored at their last visit, and they therefore did not contribute to any risk set between that visit and death. Accordingly, exposed subjects tended to be under-represented in risk sets, leading to an overestimation of the exposure effect on the disease (the relative biases ranged from þ12.0% to þ80.1%). By contrast, when the effect of the exposure on death was much stronger in diseased subjects (Scenario 4), exposed diseased subjects tended to die shortly after their disease onset, possibly before being diagnosed. Accordingly, exposed subjects were under-represented among diagnosed subjects, which induced a strong underestimation of the adverse exposure effect on the disease (the relative biases ranged from À26.5% to À88.4%). When the effect of the exposure on death was similar in diseased and disease-free subjects (Scenario 5), both phenomena of underestimation and overestimation compensated for each other, resulting in less biased estimates (the relative biases ranged from À29.4% to þ20.8%). When the exposure moderately increased the risk of death in diseased subjects, but decreased it in disease-free subjects (Scenario 6), under-representation of exposed subjects in diagnosed subjects induced an overestimation of the protective effect of the exposure on the risk of disease (the relative bias ranged from þ5.5% to þ27.5%).
Application to dementia
Among the 3675 dementia-free PAQUID subjects at baseline, 663 never had any follow-up visit, leaving 3012 subjects for Models 1-3. For all participants without follow-up, we had the date of death or the alive status at some point in time during the 20-year follow-up, giving 3675 subjects for Model 4. Among the 3675 subjects, 832 (22.6%) were diagnosed with dementia at some visit, including 639 (76.8%) subjects who died thereafter. Among the 2843 subjects who were never diagnosed with dementia, 2298 (80.8%) died. The overall percentages of events are therefore close to those simulated in the scenarios with high event rates ( Table 2 ). The time elapsed between the last visit and death was longer than 10 years for 250 subjects, which may be long enough to develop dementia. Because age-specific incidence of dementia and mortality rate depend on sex, 13, 15 separate analyses were conducted in men and women. All models included indicators of (i) primary school certificate, (ii) baseline self-reported systolic blood pressure (SBP) higher than 160 mmHg and/or diastolic blood pressure (DBP) higher than 95 mmHg and (iii) ever smoking at baseline. All models also included birth year as a continuous covariate to adjust for calendar period and/or birth cohort effects. Selected subjects characteristics are described in Table 4 .
As expected, the risk of dementia was lower in subjects with the primary school certificate in both men and women (Table 5 ). However, the estimated effect in men was stronger by 36% with Models 1-3 than with Model 4 ( 01 ¼ À0.87 versus À0.64). This is likely due to the fact that, whereas educated men had lower risk of dementia than less educated men (HR 01 ¼ 0.53, 95% CI: 0.37, 0.76; Model 4), they tended to have higher risk of death once they 25 Educated men were therefore likely under-represented among subjects diagnosed with dementia in Models 1-3, potentially leading to an overestimation of the protective effect of education on dementia, as in Scenario 6 of simulations (Table 3) . Despite the association between high SBP/DBP and death in dementia-free women (HR 02 ¼ 1.38, 95% CI: 1.02, 1.86; Model 4), Models 1-3 did not reject the null hypothesis of no effect of SBP/DBP on dementia (HR 01 ¼ 1.25, 95% CI: 0.93, 1.67; Model 1). Similarly, despite the association between smoking and death in dementia-free men (HR 02 ¼ 1.65, 95% CI: 1.29, 2.11; Model 4), Models 1-3 did not reject the null hypothesis of no effect of smoking on dementia (HR 01 ¼ 1.15, 95% CI: 0.82, 1.60; Model 1). The effects of high SBP/DBP and smoking on death were probably not strong enough 
Discussion
The illness-death model for interval-censored data, as compared with standard survival models, resulted in better estimates of the effects on disease of exposures that were associated with death, especially when the mortality rates were high. The superiority of the illness-death model was due to its ability to account for the probability of developing the disease between the last visit and death. The direction and magnitude of the bias from the standard models depended on the exposure effects on disease and death in both diseased and disease-free subjects.
As in most simulation studies, we investigated only a limited range of scenarios and imposed some restrictive assumptions. In particular, we imposed constant effects of only one time-independent covariate. All analytical models which assumed proportional transition intensities were thus correctly specified. Yet, it would be of interest to investigate the impact of model misspecification. We also assumed that death was the only source of dependent censoring. Yet, subjects who were lost-to-follow-up may have different risks of disease and/or death. To account for this, the illness-death model for interval-censored data can be extended as described in Barrett et al., 26 by imposing some additional assumptions and constraints on the model parameters. Further simulations would be necessary to investigate the advantage of this model as compared with our simpler but more flexible semi-parametric illness-death model for interval-censored data. Similarly, we assumed in both simulations and application that visit times were independent of the illness-death process. This independence assumption is reasonable in the PAQUID study where the visits are scheduled in advance independently of any outcome. Finally, we used a Markov illness-death model and thus assumed that mortality rates in diseased subjects depended only on age and exposures, and not on disease duration. It would be of interest to investigate the impact of the violation of such assumption in further simulation studies. However, this assumption is in agreement with a previous study that found that a Markov model better fitted the PAQUID women's data than two semiMarkov models where mortality rates in diseased subjects depended on disease duration or on both disease duration and age. 19 Note that because of interval censoring, the estimation of the latter semi-Markov is not straightforward and not yet implemented in the SmoothHazard R package.
When the disease status may be misclassified, hidden Markov models could be estimated using the msm R package 27 which also handles interval censoring and allows estimation of covariate effects on all transition intensities. However, constant or piecewise constant transition intensities have to be assumed as opposed to the SmoothHazard R package that allows smooth non-parametric estimation of transition intensities, as well as parametric estimation assuming Weibull distributions. Multiple imputation for the age at dementia has been proposed as an alternative to penalized likelihood. 28 However, this requires a first step of imputation, and the need to rely on an appropriate imputation model. Fully nonparametric estimation has also been proposed, 16 but to our knowledge it does not allow the incorporation of covariates in the model.
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